Uncategorized

Catalent and Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of MCO-010

by Business Wire • 2026/07/07 • 0 Comments

TAMPA, Fla. & DALLAS--(BUSINESS WIRE)--Catalent & Nanoscope Therapeutics Expand Partnership to Support Late-Phase Development and Commercial Supply of Lead Optogenetic Gene Therapy, MCO-010

← ‘Unlearning learned helplessness’ in medicine requires partnership of physicians, patients

The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials →

Post navigation